Cargando…

Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial

AIMS/INTRODUCTION: The pathophysiology of diabetes differs between Asian and Western patients in many ways, and diet is a primary contributor. The present study examined the effect of diet on the efficacy of 25% insulin lispro/75% insulin lispro protamine suspension (LM25) and 50% insulin lispro/50%...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Qian, Lei, Watada, Hirotaka, Li, Peng Fei, Iwamoto, Noriyuki, Imori, Makoto, Yang, Wen Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217926/
https://www.ncbi.nlm.nih.gov/pubmed/27287069
http://dx.doi.org/10.1111/jdi.12547
_version_ 1782492177486577664
author Chen, Wei
Qian, Lei
Watada, Hirotaka
Li, Peng Fei
Iwamoto, Noriyuki
Imori, Makoto
Yang, Wen Ying
author_facet Chen, Wei
Qian, Lei
Watada, Hirotaka
Li, Peng Fei
Iwamoto, Noriyuki
Imori, Makoto
Yang, Wen Ying
author_sort Chen, Wei
collection PubMed
description AIMS/INTRODUCTION: The pathophysiology of diabetes differs between Asian and Western patients in many ways, and diet is a primary contributor. The present study examined the effect of diet on the efficacy of 25% insulin lispro/75% insulin lispro protamine suspension (LM25) and 50% insulin lispro/50% insulin lispro protamine suspension (LM50) as starter insulin in Chinese and Japanese patients with type 2 diabetes and inadequate glycemic control with oral antidiabetic medication. MATERIALS AND METHODS: This was a predefined subgroup analysis of a phase 4, open‐label, 26‐week, parallel‐arm, randomized (computer‐generated random sequence) trial (21 January 2013 to 22 August 2014). Nutritional intake was assessed from food records kept by participants before study drug administration. Outcomes assessed were changes from baseline in self‐monitored blood glucose, 1,5‐anhydroglucitol and glycated hemoglobin. RESULTS: In total, 328 participants were randomized to receive twice‐daily LM25 (n = 168) or LM50 (n = 160). Median daily nutritional intake (by weight and percentage of total energy) was 230.8 g of carbohydrate (54%), 56.5 g of fat (31%) and 66 g of protein (15%). Improvements in self‐monitored blood glucose were significantly greater (P ≤ 0.028) in the LM50 group than in the LM25 group, regardless of nutritional intake. When carbohydrate (by weight or percentage energy) or fat (by weight) intake exceeded median levels, LM50 was significantly more efficacious than LM25 (P ≤ 0.026) in improving 1,5‐anhydroglucitol and glycated hemoglobin. CONCLUSIONS: Glycemic control improved in both LM25 and LM50 groups, but LM50 was significantly more efficacious under certain dietary conditions, particularly with increased carbohydrate intake.
format Online
Article
Text
id pubmed-5217926
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52179262017-01-09 Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial Chen, Wei Qian, Lei Watada, Hirotaka Li, Peng Fei Iwamoto, Noriyuki Imori, Makoto Yang, Wen Ying J Diabetes Investig Articles AIMS/INTRODUCTION: The pathophysiology of diabetes differs between Asian and Western patients in many ways, and diet is a primary contributor. The present study examined the effect of diet on the efficacy of 25% insulin lispro/75% insulin lispro protamine suspension (LM25) and 50% insulin lispro/50% insulin lispro protamine suspension (LM50) as starter insulin in Chinese and Japanese patients with type 2 diabetes and inadequate glycemic control with oral antidiabetic medication. MATERIALS AND METHODS: This was a predefined subgroup analysis of a phase 4, open‐label, 26‐week, parallel‐arm, randomized (computer‐generated random sequence) trial (21 January 2013 to 22 August 2014). Nutritional intake was assessed from food records kept by participants before study drug administration. Outcomes assessed were changes from baseline in self‐monitored blood glucose, 1,5‐anhydroglucitol and glycated hemoglobin. RESULTS: In total, 328 participants were randomized to receive twice‐daily LM25 (n = 168) or LM50 (n = 160). Median daily nutritional intake (by weight and percentage of total energy) was 230.8 g of carbohydrate (54%), 56.5 g of fat (31%) and 66 g of protein (15%). Improvements in self‐monitored blood glucose were significantly greater (P ≤ 0.028) in the LM50 group than in the LM25 group, regardless of nutritional intake. When carbohydrate (by weight or percentage energy) or fat (by weight) intake exceeded median levels, LM50 was significantly more efficacious than LM25 (P ≤ 0.026) in improving 1,5‐anhydroglucitol and glycated hemoglobin. CONCLUSIONS: Glycemic control improved in both LM25 and LM50 groups, but LM50 was significantly more efficacious under certain dietary conditions, particularly with increased carbohydrate intake. John Wiley and Sons Inc. 2016-10-05 2017-01 /pmc/articles/PMC5217926/ /pubmed/27287069 http://dx.doi.org/10.1111/jdi.12547 Text en © 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Chen, Wei
Qian, Lei
Watada, Hirotaka
Li, Peng Fei
Iwamoto, Noriyuki
Imori, Makoto
Yang, Wen Ying
Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial
title Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial
title_full Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial
title_fullStr Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial
title_full_unstemmed Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial
title_short Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial
title_sort impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in east asian patients with type 2 diabetes: subgroup analysis of the comparison between low mixed insulin and mid mixed insulin as starter insulin for patients with type 2 diabetes mellitus (classify study) randomized trial
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217926/
https://www.ncbi.nlm.nih.gov/pubmed/27287069
http://dx.doi.org/10.1111/jdi.12547
work_keys_str_mv AT chenwei impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr
AT qianlei impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr
AT watadahirotaka impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr
AT lipengfei impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr
AT iwamotonoriyuki impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr
AT imorimakoto impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr
AT yangwenying impactofdietontheefficacyofinsulinlispromix25andinsulinlispromix50asstarterinsulinineastasianpatientswithtype2diabetessubgroupanalysisofthecomparisonbetweenlowmixedinsulinandmidmixedinsulinasstarterinsulinforpatientswithtype2diabetesmellitusclassifystudyr